These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The case for a lower dose pill. Assessing the impact of estrogen dose. Brown S, Cropfield O. ORGYN; 1995; (2):36-9. PubMed ID: 12319251 [Abstract] [Full Text] [Related]
26. Clinical pharmacology of the steroidal oral contraceptives. Durand JL, Bressler R. Adv Intern Med; 1979; 24():97-126. PubMed ID: 371370 [Abstract] [Full Text] [Related]
30. [Oral contraception: evolution of concepts over the last thirty years]. Belaisch J, Hommais-loufrani B. Contracept Fertil Sex (Paris); 1987 Nov 30; 15(11 Suppl):1-8. PubMed ID: 12281408 [Abstract] [Full Text] [Related]
31. British pill studies stress importance of relation between progestogen content and vascular disease. Fam Plann Perspect; 1980 Nov 30; 12(5):262-4. PubMed ID: 7439351 [Abstract] [Full Text] [Related]
34. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Tanis BC, Rosendaal FR. Semin Vasc Med; 2003 Feb 30; 3(1):69-84. PubMed ID: 15199494 [Abstract] [Full Text] [Related]
35. The choice of the dose of oestrogen in a combined oral contraceptive. Smith M. Fertil Contracept; 1978 Apr 30; 2(2):22-3. PubMed ID: 12336093 [Abstract] [Full Text] [Related]